Curaleaf Holdings, Inc.
Other OTCRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- Curaleaf Holdings, Inc. is a leading vertically integrated cannabis company engaged in the cultivation, processing, manufacturing, and distribution of cannabis products primarily in the United States, with expanding international operations. Founded in 2010 and headquartered in New York City, Curaleaf operates across approximately 17 states in the U.S., with a substantial footprint consisting of 151 dispensaries, 19 cultivation sites, and 20 manufacturing facilities. The company's product portfolio includes cannabis flower, pre-rolls, flower pods, dry-herb vaporizer cartridges, concentrates for vaporizing and dabbing, including pre-filled cartridges and disposable pens, as well as edibles, tinctures, topicals, mints, lozenges, capsules, and hemp-derived products such as cannabidiol (CBD) and cannabigerol (CBG) items. Curaleaf serves both medical and adult-use markets through its diverse brands including Curaleaf, Select, Grassroots, JAMS, Find, The Hemp Company, and Zero Proof. In the last 1-2 years, Curaleaf has pursued aggressive expansion and innovation strategies. The company launched a new pre-roll brand and expanded its hemp-derived beverage line with new products including Select Zero Proof seltzers and The Hemp Co. hemp-derived THC seltzers distributed in multiple states through major retailers such as Total Wine. Curaleaf also introduced the Reef flower brand in Florida and expanded retail operations with new dispensaries opening in key growth states such as Florida and New York. Financially, Curaleaf secured a $40 million revolving credit facility with a major commercial regional bank, marking a significant milestone in cannabis company financing. The company’s strategic direction focuses on organic growth, margin optimization, international expansion, and deployment of advanced technology platforms such as ACE for operational improvements. Curaleaf’s recent initiatives reflect its positioning as the largest cannabis company by revenue in the U.S., operating in highly regulated populous states with an emphasis on product innovation and quality assurance. Curaleaf’s business model relies on vertical integration, controlling its supply chain from cultivation through retail, ensuring product quality and cost efficiency. It targets a broad consumer base comprising medical patients and recreational users, catering to diverse preferences through a wide range of premium cannabis-derived products. The company is known for its rigorous safety, efficacy, and consistency standards upheld through extensive research and development. Curaleaf continues to expand its retail footprint and manufacturing capacity to consolidate leadership in the multi-state operator (MSO) cannabis market while advancing its hemp division and international sales. Its operations emphasize compliance with regulatory frameworks and fostering industry education and advocacy in the evolving cannabis sector. Curaleaf employs approximately 5,500 staff and reports annual revenues of approximately $1.3 billion, maintaining strong cash flow generation despite market challenges. This description reflects Curaleaf Holdings, Inc.’s current industry standing, business activities, product range, geographic presence, and recent strategic developments as of late 2025.
Curaleaf to Report Second Quarter 2026 Financial and Operational Results
Curaleaf Announces Results of its 2026 Shareholders Meeting
3 Leading Marijuana Stocks Investors Are Watching in June 2026
The Single Biggest Cannabis Catalyst in Years Is Rapidly Approaching: 2 Marijuana Stocks to Buy Now
Curaleaf Confirms Effective Date of Reverse Stock Split
Buying for the Long Haul? These 3 Stocks Could Generate 10x Returns
Best Marijuana Stocks to Watch for Potential Upside in June 2026
Better Buy: Green Thumb Industries vs. Curaleaf Holdings
Cannabis Stocks Are Heating Up Again. Here's Which Ones Could be the Biggest Winners.
Curaleaf Prepares for US Exchange Uplisting: Time to Invest?
Curaleaf Announces 1-for-3 Reverse Stock Split in Preparation for U.S. Stock Exchange Uplisting
3 Marijuana Stocks To Know About Now In 2026
Green Thumb Industries vs. Curaleaf Holdings: Which Cannabis Stock Could Win Biggest From DEA Rescheduling?
Curaleaf Bolsters Florida Footprint with Two New Medical Dispensaries in Jacksonville Beach and Fernandina Beach
Here Is How Marijuana Stocks Are Setting Up To Run In 2026
Curaleaf Holdings, Inc. (CURA:CA) Q1 2026 Earnings Call Transcript
Curaleaf Holdings, Inc. (CURLF) Q1 Earnings and Revenues Top Estimates
Curaleaf Reports First Quarter 2026 Results: Robust Growth and Net Income
Curaleaf Announces Appointment of Torsten Greif to Board of Directors
Curaleaf Completes Buyout of Remaining Stake in Germany's Four 20 Pharma